1. Laboratory of Immunochemistry, Serbsky National Research Center for Social and Forensic Psychiatry 2. Insitute of Protein Research, Russian Academy of Sciences
PEGylated (stealth) immunoliposomes covalently linked to antibodies against humal gliofibrillary acidic protein (GFAP) were prepared by coupling the thiolated monoclonal anti-GFAP antibodies, D4, with a maleimide derivative of the phosphatidyl ethanolamine of the liposomal membrane. Depending on initial protein-to-lipid rations, the immunoliposomes prepared (with a diameter of about 70 nm) were coupled with 60 to 240 molecules of the antibodies. In vitro experiments with cultures of the embryonic rat brain astrocytes demonstrated a specific binding of these immunoliposomes, which could be inhibited by the preincubation of the cells with free non-coupled D4 but not with non-specific antibodies. Administered intravenously into rats, the immunoliposomes exhibited a kinetic behavior typical for the PEGylated liposomes: after 24 h, approximately 20% of the doses injected were still present in the blood; the elimination rate constants were 0.05-0.09 h-1, the elimination half-lives were 8-15 h. With such a systemic longevity, as well as with such a specificity, these immunoliposomes, non-penetrating through intact blood-brain barrier (BBB), should be useful in delivering pharmacological agents to glial brain tumours (which continue to express GFAP) or to other pathological loci in the brain with a partially disintegrated BBB.
Chekhonin V.P. et al. Pegylated immunoliposomes directed against embryonal rat brain astrocytes // Biomeditsinskaya Khimiya. - 2005. - V. 51. -N 3. - P. 276-286.
Chekhonin V.P. et al., "Pegylated immunoliposomes directed against embryonal rat brain astrocytes." Biomeditsinskaya Khimiya 51.3 (2005): 276-286.
Chekhonin, V. P., Zhirkov, Yu. A., Gurina, O. I., Lebedev, S. V., Dmitriyeva, T. B., Semenova, A. V., Jaglova, T. V., Rjabinina, , A. E. (2005). Pegylated immunoliposomes directed against embryonal rat brain astrocytes. Biomeditsinskaya Khimiya, 51(3), 276-286.
References
Cerletti A., Drewe J., Fricker G., Eberle A.N., Huwyler J. (2000) J. Drug Targeting, 8, 435-446. Scholar google search
Gutman R.L., Peacock G., Lu D.R. (2000) J. Controled Release, 65, 31-41. Scholar google search
Huwyler J., Wu D., Pardridge W.M. (1996) Proc. Natl. Acad. Sci. USA, 93, 14164-14169. Scholar google search
Shi N., Boado R.J., Pardridge W.M. (2000) Proc. Natl. Acad. Sci. USA, 97, 14709-14714. Scholar google search
Shi N.,Pardridge W.M. (2000) Proc. Natl. Acad. Sci. USA, 97, 7567-7572. Scholar google search
Wu D., Pardridge W.M. (1999) Proc. Natl. Acad. Sci. USA, 96, 254-259. Scholar google search
Чехонин В.П., Дмитриева Т.Е., Жирков Ю.А. (2000) Иммунохимический анализ нейроспецифических антигенов.—М :Медицина. Scholar google search
